ARX:ASX
Aroa Biosurgery Ltd
A$0.50
arrow_upward
+1.00%(+0.0050) 1D
Nov 16, 10:00:01 AM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.51
High
A$0.51
Low
A$0.50
Mkt. cap
174.68M
Avg. vol.
288.42K
Volume
10.36K
P/E ratio
48.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.51
High
A$0.51
Low
A$0.50
Mkt. cap
174.68M
Avg. vol.
288.42K
Volume
10.36K
P/E ratio
48.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
AOL.com
·
3 hours ago
Berkshire’s record high exposes hidden trap in S&P 500 401(k) plans
Longbridge
·
2 days ago
[Weekly Recap] CTA Net Position Hits Extreme Low, Nasdaq…
Benzinga
·
3 hours ago
Dow Jones, Nasdaq 100, and S&P 500 Outlooks: Key Stock Market News This Week
The Motley Fool
·
5 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd